Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
A first-in-human study of the oral selective androgen receptor down-regulating drug (SARD) AZD3514 in patients with castration-resistant prostate cancer (CRPC) [abstract]
Cas No.: 17298-37-2 Sample solution is provided at 25 L, 10mM
Directing GLP-1 prescriptions through specific vendors or specialty pharmacies can improve pricing transparency and rebate capture
Hentze, M
To the 10.000 rpm supernatant containing microsomes and cytosol fractions, 0.2 volume of 0.1 M calcium chloride solution was added, and further centrifuged at 10,000 rpm for 10 minutes to precipitate the microsomes
Building and maintaining muscle mass increases resting metabolic rate and improves body composition
